These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26586845)

  • 1. On the repeated measures designs and sample sizes for randomized controlled trials.
    Tango T
    Biostatistics; 2016 Apr; 17(2):334-49. PubMed ID: 26586845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power and sample size for the S:T repeated measures design combined with a linear mixed-effects model allowing for missing data.
    Tango T
    J Biopharm Stat; 2017; 27(6):963-974. PubMed ID: 28319460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size estimation for GEE method for comparing slopes in repeated measurements data.
    Jung SH; Ahn C
    Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On model selections for repeated measurement data in clinical studies.
    Zou B; Jin B; Koch GG; Zhou H; Borst SE; Menon S; Shuster JJ
    Stat Med; 2015 May; 34(10):1621-33. PubMed ID: 25645442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design.
    Frison L; Pocock SJ
    Stat Med; 1992 Sep; 11(13):1685-704. PubMed ID: 1485053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of constrained randomization for the design and analysis of group-randomized trials with binary outcomes.
    Li F; Turner EL; Heagerty PJ; Murray DM; Vollmer WM; DeLong ER
    Stat Med; 2017 Oct; 36(24):3791-3806. PubMed ID: 28786223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
    Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
    Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values.
    Li J; Yang X; Wu Y; Shoptaw S
    Stat Med; 2007 May; 26(12):2519-32. PubMed ID: 17106918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a flexible piecewise linear mixed-effects model in the analysis of randomized cross-over trials.
    Mwangi M; Verbeke G; Njagi EN; Florez AJ; Mwalili S; Ivanova A; Bukania ZN; Molenberghs G
    Pharm Stat; 2024; 23(3):370-384. PubMed ID: 38146135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of mixed model repeated measures analyses and non-linear random coefficient models in the context of long-term efficacy data.
    Delafont B; Carroll K; Vilain C; Pham E
    Pharm Stat; 2018 Sep; 17(5):515-526. PubMed ID: 29781237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missing not at random models for masked clinical trials with dropouts.
    Kang S; Little RJ; Kaciroti N
    Clin Trials; 2015 Apr; 12(2):139-48. PubMed ID: 25627429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of missing data on type 1 error rates in non-inferiority trials.
    Yoo B
    Pharm Stat; 2010; 9(2):87-99. PubMed ID: 19408241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Contemp Clin Trials; 2006 Feb; 27(1):57-69. PubMed ID: 16260188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
    Takada M; Sozu T; Sato T
    Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Handling baselines in repeated measures analyses with missing data at random.
    Dinh P; Yang P
    J Biopharm Stat; 2011 Mar; 21(2):326-41. PubMed ID: 21391005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for treatment effect in covariate-adaptive randomized trials with generalized linear models and omitted covariates.
    Li Y; Ma W; Qin Y; Hu F
    Stat Methods Med Res; 2021 Sep; 30(9):2148-2164. PubMed ID: 33899607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of tests under covariate-adaptive biased coin randomization and generalized linear models.
    Shao J; Yu X
    Biometrics; 2013 Dec; 69(4):960-9. PubMed ID: 23848580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline adjustments for binary data in repeated cross-sectional cluster randomized trials.
    Nixon RM; Thompson SG
    Stat Med; 2003 Sep; 22(17):2673-92. PubMed ID: 12939779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment effects in randomized longitudinal trials with different types of nonignorable dropout.
    Yang M; Maxwell SE
    Psychol Methods; 2014 Jun; 19(2):188-210. PubMed ID: 24079928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.